KRISTEN YOST: Open Payments
NPI 1609527696 · GRANVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 14 payments from 7 companies in 2025. Trend: 2023 $19 · 2024 $181 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $89 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Novo Nordisk Inc | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: QULIPTA, Ozempic, TRELEGY ELLIPTA, VRAYLAR, AREXVY, GVOKE HYPOPEN, UBRELVY, Auvelity.
Industry payments across OH — which companies pay providers there.
